CIRM Funded Clinical Trials
Sequential same donor αβdepleted-HSCT from an HLA-partially matched donor allowing immunosuppression free kidney transplant
Sequential same donor αβdepleted-HSCT from an HLA-partially matched donor allowing immunosuppression free kidney transplant
Disease Area:
Anemia
Bone Marrow Transplant and Viral Infection
Investigator:
Institution:
CIRM Grant:
Award Value:
$11,998,188
Trial Sponsor:
Stanford University
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A
